全球扁桃体和腺样体切除产品市场 - 2023-2030

概述

全球扁桃体和腺样体切除产品市场于 2022 年达到 7 亿美元，预计到 2030 年将达到 12 亿美元，2023-2030 年预测期间复合年增长率为 7.4%。

扁桃体和腺样体切除技术用于扁桃体和腺样体的手术切除。扁桃体和腺样体是淋巴系统的一部分，分别位于喉咙和鼻腔的后部。它们是免疫过程的一部分，但当它们扩大或感染时，可能会导致呼吸问题、打鼾和睡眠呼吸暂停。

该市场受到扁桃体和腺样体相关疾病患病率上升的推动，包括睡眠呼吸暂停和慢性扁桃体炎，导致扁桃体和腺样体切除手术数量增加。此外，扁桃体和腺样体切除产品开发的技术进步推动了这一需求，这些技术进步引导了更安全、更有效的方法。

动力学

扁桃体和腺样体相关疾病的患病率不断增加推动了扁桃体和腺样体切除产品市场的增长

扁桃体和腺样体相关疾病的日益流行预计将在预测期内推动全球扁桃体和腺样体切除产品市场的发展。例如，根据国家生物技术信息中心的数据，2022 年 8 月，美国每年进行超过 50 万例扁桃体切除术。该地区呼吸道感染也很常见，这再次有助于扁桃体和腺样体器官的手术干预。

此外，在最近公布的SPLIT 调查中，人类疱疹病毒6 (HHV6)、7 (HHV7) 和Epstein-Barr 病毒(EBV) 是扁桃体组织中遇到的高度典型的疱疹病毒（50%、70%、70 %）。再次，择期腺样体扁桃体切除术患者的腺样体组织中发现了HHV6、HHV7、EBV和鉅细胞病毒（CMV），优势率波动在20%-77%、50%-77%、43%- 73%之间。分别为3%-50%。

扁桃体切除术研究活动的增加预计将为全球扁桃体和腺样体切除产品市场带来增长机会

扁桃体切除术研究活动的增加预计将为全球扁桃体和腺样体切除产品市场带来未来几年的潜在增长机会。

例如，2023 年 3 月，在 UT 西南医学中心的一个小组的指导下，研究人员制定了一项统计标准，以确定小儿扁桃体切除术后出血率标准、高或低的标准。该结论发表在《美国医学会杂誌耳鼻喉科-头颈外科》上，可以让医生和医院提高美国第三大典型儿科手术的结果

扁桃体切除手术并发症预计将在预测期内阻碍全球扁桃体和腺样体切除产品市场

扁桃体切除术的一些典型并发症是术后感染、出血、舌头水肿、舌咽神经损伤和颈动脉损伤。扁桃体切除术最典型但严重的复杂性是迟发性出血，所有患者中 2% 至 4% 会发生迟发性出血。此外，该过程的预期后遗症是疼痛，通常持续 7 至 10 天，强度从中度到重度不等。

目录

第 1 章：方法和范围

• 研究方法论
• 报告的研究目的和范围

第 2 章：定义和概述

第 3 章：执行摘要

• 按产品类型分類的片段
• 技术片段
• 最终用户摘录
• 按地区分類的片段

第 4 章：动力学

• 影响因素
  • 司机
    • 扁桃体和腺样体相关疾病的患病率不断增加
    • 市场动态
  • 限制
    • 手术并发症的威胁
  • 机会
    • 增加研究活动
  • 影响分析

第 5 章：行业分析

• 波特五力分析
• 供应链分析
• 定价分析
• 监管分析

第 6 章：COVID-19 分析

• COVID-19 分析
  • COVID-19 之前的情况
  • COVID-19 期间的情况
  • COVID-19 后的情景
• COVID-19 期间的定价动态
• 供需谱
• 疫情期间政府与市场相关的倡议
• 製造商的战略倡议
• 结论

第 7 章：按产品类型

• 扁桃体切除产品
  • 钳子
  • 线环
  • 剪刀
• 腺样体切除产品
  • 微清创器

第 8 章：按技术

• 等离子消融术
• 电灼术 (ECT)
• 谐波手术刀
• 其他的

第 9 章：最终用户

• 医院
• 专科诊所
• 门诊手术中心
• 其他

第 10 章：按地区

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 意大利
  • 欧洲其他地区
• 南美洲
  • 巴西
  • 阿根廷
  • 南美洲其他地区
• 亚太
  • 中国
  • 印度
  • 日本
  • 亚太其他地区
• 中东和非洲
  • 关键地区特定动态

第 11 章：竞争格局

• 竞争场景
• 市场定位/份额分析
• 併购分析

第 12 章：公司简介

• Medtronic
• 公司简介
• 产品组合和描述
• 财务概览
• 主要进展
• BAUSCH & LOMB INCORPORATED
• Olympus America
• New Med Instruments
• Medelecsurgical
• Smith & Nephew
• Advin Health Care
• Deluxe Scientific Surgico Pvt Ltd.
• EON Meditech
• Integra LifeSciences

第 13 章：附录

• 关于我们和产品

Overview

Global Tonsil and Adenoid Removal Products market reached US$ 0.7 billion in 2022 and is expected to reach US$ 1.2 billion by 2030 growing with a CAGR of 7.4% during the forecast period 2023-2030.

Tonsil and adenoid removal developments are employed in the surgical reduction of tonsils and adenoids. Tonsils and adenoids are parts of the lymphatic system situated in the rear of the throat and nasal cavity, respectively. They function as part of the immune process, though when they become broadened or infected, they can lead to breathing problems, snoring, and sleep apnea.

The market is driven by the rising prevalence of tonsils and adenoid-associated conditions, including sleep apnea and chronic tonsillitis leading to incrase in number of tonsil and adenoid removal procedures. Furthermore, the demand is pushed by technological advances in tonsil and adenoid removal product developments, which have guided securer and more efficacious approaches.

Dynamics

The Increasing Prevalence of Tonsils and Adenoid-Associated Conditions Drive the Growth of the Tonsil and Adenoid Removal Products Market

The increasing prevalence of tonsils and adenoid-associated conditions is expected to boost the global tonsil and adenoid removal products market during the forecast period. For instance, according to the National Center for Biotechnology Information, in August 2022, more than 500,000 operations of tonsillectomies were conducted annually in the United States. The region also has a high preponderance of respiratory infections which again contributes to the surgical interventions of the tonsil and adenoid organs.

Moreover, in the lately publicized SPLIT investigation, human herpesviruses 6 (HHV6), 7 (HHV7), and Epstein-Barr virus (EBV) were the highly typical herpesviruses encountered in the tonsil tissue (50%, 70%, 70%). Again, HHV6, HHV7, EBV, and cytomegalovirus (CMV) have been caught in adenoid tissue of elective adenotonsillectomy patients, the preponderance rates fluctuating in the scopes of 20%-77%, 50%-77%, 43%-73%, and 3%-50%, respectively.

The Increasing Research Activities for Tonsillectomy Procedures are Expected to Present the Global Tonsil and Adenoid Removal Products Market With Growth Opportunities

Increasing research activities for tonsillectomy procedures are expected to present the global tonsil and adenoid removal products market with prospective growth opportunities in the forthcoming years.

For instance, in March 2023 researchers guided by a group at UT Southwestern Medical Center developed a statistical standard to determine criteria for standard, high, or low rates of bleeding post-pediatric tonsillectomies. The conclusions, published in JAMA Otolaryngology-Head & Neck Surgery, could allow doctors and hospitals to enhance results for the third-most typical pediatric surgery in the U.S.

The Tonsillectomy Surgery Complications is Expected to Hamper the Global Tonsil and Adenoid Removal Products Market During the Forecast Period

Some typical complications of tonsillectomy are postoperative infection, bleeding, edema of the tongue, glossopharyngeal nerve injury, and carotid artery damage. The highly typical but serious intricacy of tonsillectomy is delayed hemorrhage, which transpires in 2% to 4% of all patients. Further, an anticipated sequela of the process is pain, which commonly stays from 7 to 10 days and varies from moderate to severe in intensity.

Segment Analysis

The global tonsil and adenoid removal products market is segmented based on product type, technology, end-users, and region.

The Coblation Technique Technology Type is Estimated to Dominate the Global Tonsil and Adenoid Removal Products Market

The coblation technique technology type is expected to hold around 37.8% of the global market share owing to improved outcomes from this technique compared to others. For instance, in March 2023, Smith+Nephew, the multinational medical technology corporation, declared the outcomes from a recent scientific investigation that demonstrates its COBLATION Intracapsular Tonsillectomy (CIT) procedure can guide to enhanced post-operative results in patients versus total tonsillectomy procedures. The investigation was lately publicized online by OTO Open Journal titled The Open Access Journal of the American Academy of Otolaryngology-Head and Neck Surgery Foundation.

Geographical Penetration

North America is Estimated to hold Approximately 38.8% of the Market Share by 2030, Owing to Increasing Cases of Tonsils and Adinosides Associated Disorders in this Region

Owing to the increasing cases of tonsils and adinosides associated disorders in the North America region, it is estimated to dominate the global market holding around 38.3% of the market by 2030. For instance, according to the American Academy of Otolaryngology-Head and Neck Surgery, a tonsillectomy is one of the most typically conducted surgical operations in United states. More than 500,000 surgeries are performed yearly in children below 15 years of age.

Two standard causes for this surgery includes sleep-disordered breathing and recurrent throat disorders. Moreover, sleep apnea is predominant and diagnosed in around 18 million Americans alone. This statistic signifies that roughly 1 in every 15 Americans, or 6.62% of the total American population have sleep apnea. Further, approximately 2% of ambulatory patient visits in the United States are because of sore throat. Though it is highly expected in winter and early spring, the condition can transpire at any period during the year. The group A beta-hemolytic Streptococcus GABHS makes up for 5% to 15% of adults with pharyngitis and 15% to 30% of patients between the years of five and fifteen.

Competitive Landscape

The major global players in the tonsil & adenoid removal products market include: Medtronic, BAUSCH & LOMB INCORPORATED, Olympus America, New Med Instruments, medelecsurgical, Smith & Nephew, Advin Health Care, and Deluxe Scientific Surgico Pvt Ltd, among others.

COVID-19 Impact Analysis

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict is assumed to have had a very moderate impact on the global tonsil and adenoid removal products market, as this region lacks primary market players. However, during the 3 months of full-scale warfare, Russians sabotaged over 600 infirmaries and massacred at least 12 medics. Access to health care is majorly affected because of security considerations, limited mobility, damaged supply chains, and mass population eviction. In addition, the import and export of fundamental materials' significance is expected to slightly impact the global tonsil & adenoid removal products market growth in the forecast period.

By Product Type

• Tonsils Removal Products
  • Forceps
  • Wire loop
  • Scissors

• Adenoid Removal Products
  • Microdebrider

By Technology

• Coblation
• Electrocautery (ECT)
• Harmonic scalpel
• Other

By End-Users

• Hospital
• Specialty Clinics
• Ambulatory surgical centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• In September 2022, Olympus America introduced its state-of-the-art energy device accurate dissection equipment, THUNDERBEAT Open Fine Jaw Type X surgical energy instruments. It delivers fine dissection utilizing cutting-edge bipolar energy.
• In February 2022 Pristyn Care, a health technology, and secondary-care surgeries start-up, declared that it had expanded its surgical centers to 800 in India, in 2021.

Why Purchase the Report?

• To visualize the global tonsil and adenoid removal products market segmentation based on product type, technology, end-users and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous tonsil and adenoid removal products market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available in excel consisting of key products of all the major players.

The global tonsil and adenoid removal products market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Technology
• 3.3. Snippet by End-Users
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Tonsils and Adenoids Associated Conditions
    • 4.1.1.2. Market Developments
  • 4.1.2. Restraints
    • 4.1.2.1. Threat of Surgical Complications
  • 4.1.3. Opportunity
    • 4.1.3.1. Increasing Research Activities
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers' Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Tonsils Removal Products *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.2.3. Forceps
  • 7.2.4. Wire loop
  • 7.2.5. Scissors
• 7.3. Adenoid Removal Products
  • 7.3.1. Microdebrider

8. By Technology

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 8.1.2. Market Attractiveness Index, By Technology
• 8.2. Coblation*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Electrocautery (ECT)
• 8.4. Harmonic scalpel
• 8.5. Others

9. By End-Users

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
  • 9.1.2. Market Attractiveness Index, By End-Users
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Ambulatory surgical centers
• 9.5. Other

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. The U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Spain
    • 10.3.6.5. Italy
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan

Australia

• 10.5.6.4. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Medtronic *
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. BAUSCH & LOMB INCORPORATED
• 12.3. Olympus America
• 12.4. New Med Instruments
• 12.5. Medelecsurgical
• 12.6. Smith & Nephew
• 12.7. Advin Health Care
• 12.8. Deluxe Scientific Surgico Pvt Ltd.
• 12.9. EON Meditech
• 12.10. Integra LifeSciences

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Product
• 13.2. Contact Us